Histopathologic effects of hypofractionated robotic radiation therapy on malignant and benign prostate tissue

Technology in Cancer Research and Treatment

Volumn 9, Issue 6, 2010, Pages 583-587

  Suy, Simeng ^a   Oermann, Eric ^a   Hanscom, Heather ^a   Lei, Sue ^a   Vahdat, Saloomeh ^a   Yu, Xia ^a   Park, Hyeon U ^a   Chen, Viola ^a   Collins, Brian T ^a   McGeagh, Kevin ^a   Dawson, Nancy ^a   Jha, Reena ^a   Azumi, Norio ^a   Dritschilo, Anatoly ^a   Lynch, John ^a   Collins, Sean P ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Alpha beta ratio; Benign prostatic hyperplasia; Biochemical equivalent dose; CyberKnife; Dose escalation; High dose rate brachytherapy; Hypofractionation; Personalized therapy; Post radiotherapy prostate biopsies; Robotics; Transurethral resection of the prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; CONFORMAL HYPOFRACTIONATED RADIATION THERAPY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; MALE; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; RADIATION DOSE; STRESS INCONTINENCE; TRANSURETHRAL RESECTION; URINE RETENTION;

EID: 78650405844     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303461000900606     Document Type: Article

References (15)

1. Kuban, D. A., Tucker, S. L., Dong, L., Starkschall, G., Huang, E. H., Cheung, M. R., Lee, A. K., Pollack, A. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70, 67-74 (2008).
2. Collins, S., McRae, D., Gagnon, G., Dritschilo, A. New Directions in Radiation Therapy of Prostate Cancer: Brachytherapy and Intensity- Modulated Radiation Therapy. In: Pestell R, Nevalainen M (ed) Prostate Cancer Signaling Networks, Genetics and New Treatment Stratagies, edn. Humana Press, Totowa, NJ, pp (2008)
3. Sullivan, L., Williams, S. G., Tai, K. H., Foroudi, F., Cleeve, L., Duchesne, G. M. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol 91, 232-236 (2009).
4. Duchesne, G. M., Das, R., Toye, W., See, A. Dose distribution and morbidity after high dose rate brachytherapy for prostate cancer: influence of V150 and V200 parameters. Australas Radiol 46, 384-389 (2002).
5. King, C. R., Brooks, J. D., Gill, H., Pawlicki, T., Cotrutz, C., Presti, J. C., Jr. Stereotactic Body Radiotherapy for Localized Prostate Cancer: Interim Results of a Prospective Phase II Clinical Trial. Int J Radiat Oncol Biol Phys 73, 1043-1048 (2009).
6. Lee, W. R. Extreme hypofractionation for prostate cancer. Expert Rev Anticancer Ther 9, 61-65 (2009).
7. Cheng, L., Cheville, J. C., Bostwick, D. G. Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol 23, 1173-1183 (1999).
8. Gaudin, P. B., Zelefsky, M. J., Leibel, S. A., Fuks, Z., Reuter, V. E. Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol 23, 1021-1031 (1999).
9. Crook, J. M., Bahadur, Y. A., Robertson, S. J., Perry, G. A., Esche, B. A. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer 79, 81-89 (1997).
10. Bostwick, D. G., Meiers, I. Diagnosis of prostatic carcinoma after therapy. Arch Pathol Lab Med 131, 360-371 (2007).
11. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer In: Executive Summary NO. 13. Agency for Healthcare Research and Quality; February 2009.
12. Brenner, D. J., Hall, E. J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43, 1095-1101 (1999).
13. Fowler, J. F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44, 265-276 (2005).
14. Zelefsky, M. J., Leibel, S. A., Gaudin, P. B., Kutcher, G. J., Fleshner, N. E., Venkatramen, E. S., Reuter, V. E., Fair, W. R., Ling, C. C., Fuks, Z. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41, 491-500 (1998).
15. Kestin, L. L., Goldstein, N. S., Vicini, F. A., Mitchell, C., Gustafson, G. S., Stromberg, J. S., Chen, P. Y., Martinez, A. A. Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose- rate brachytherapy. Int J Radiat Oncol Biol Phys 54, 107-118 (2002).